Clinical Trials Logo

Hemorrhoids clinical trials

View clinical trials related to Hemorrhoids.

Filter by:

NCT ID: NCT03036111 Suspended - Hemorrhoids Clinical Trials

Effect of Topical Trimebutine on Pain After Hemorrhoidectomy

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

Trimebutine acts through smooth muscle relaxation. It is presumed that the topical application of trimebutine after hemorrhoidectomy may help relieve pain after the procedure by relaxing the internal anal sphincter spasm.

NCT ID: NCT02961855 Completed - Hemorrhoids Clinical Trials

Efficacy and Safety of CLIFE1 Gel in Benign Anorectal Surgery

Start date: January 2011
Phase: Phase 4
Study type: Interventional

Double-blinded multicenter randomized clinical trial to evaluate the efficacy and safety of CLIFE2 (lidocaine, referred as treatment A) respect CLIFE1 (lidocaine plus diclofenac, referred as treatment B) in benign anorectal surgery.

NCT ID: NCT02884076 Completed - Hemorrhoids Clinical Trials

Validation of Sodergren Score for Haemorrhoids in Malaysia

Start date: January 2017
Phase:
Study type: Observational

To validate the ability of the Sodergren score in guiding the management of symptomatic haemorrhoids in a Malaysian population.

NCT ID: NCT02851940 Withdrawn - Pain Clinical Trials

Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids

Start date: September 2016
Phase: N/A
Study type: Interventional

The investigators aim at prospectively comparing procedural pain, adverse events and rebleeding rates of anoscopic rubber band ligation and endoscopic hypertonic saline injection in patients with symptomatic hemorrhoidal disease

NCT ID: NCT02782455 Completed - Hemorrhoids Clinical Trials

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease

Start date: December 1, 2016
Phase: Phase 4
Study type: Interventional

Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When inflamed they become pathological and may present with protrusion and bleeding. A randomized, triple blind , controlled study will be conducted to compare the efficacy of calcium dobesilate against flavanoids in the management of early haemorrhoidal disease.

NCT ID: NCT02773420 Completed - Hemorrhoids Clinical Trials

HET Bipolar System: Validation of Outpatient Hemorrhoid Treatment

HET
Start date: August 2015
Phase: N/A
Study type: Interventional

Purpose: The current study aims to evaluate the safety and effectiveness of the HET™ Bipolar System (Medtronic, Boulder, CO) for the treatment of grade I-II hemorrhoids in a prospective pilot study. This device was evaluated retrospectively in a limited cohort of 23 patients previously. Methods: Patients seen at a colorectal clinic in a single institution with grade I-II hemorrhoids are offered to participate in a prospective pilot trial. The HET device is a modified anoscope equipped with LED lighting, a tissue clamping mechanism and a bipolar energy source used to treat multiple hemorrhoidal columns in one sitting. Three columns of hemorrhoids are treated with 2 heat energy applications per column. The primary outcome is the treatment effect on hemorrhoid symptoms of bleeding, pain, prolapse, itching, and soiling. This is measured with a patient completed questionnaire documenting each symptom's frequency from 0 to 3 (i.e. 0 is < 1x/month; 3 is daily) before therapy and at 3 weeks and 6 month follow-up. Post-treatment pain scores were recorded using the visual analog scale (VAS).

NCT ID: NCT02689856 Completed - Hemorrhoids Clinical Trials

Safety and Efficacy of Hydrocortisone and Lidocaine Treatment of Grade I and II Hemorrhoids

Hydro/Lido
Start date: May 2015
Phase: Phase 2
Study type: Interventional

The objectives of this study are to assess the potential contribution of lidocaine hydrochloride or hydrocortisone acetate, alone or in combination, in topical cream preparations in the treatment of Grade I or II hemorrhoids and to demonstrate the safety and efficacy of the test articles when applied twice daily for 14 days in subjects with Grade I or II hemorrhoids. These products reflect common drug combinations of lidocaine hydrochloride or hydrocortisone acetate found in many prescription hemorrhoid products.

NCT ID: NCT02654249 Completed - Hemorrhoids Clinical Trials

Prospective Randomized Trial About THD Versus Ligasure Hemorrhoidectomy for Grade III and IV Hemorrhoids

THD-LIGA
Start date: December 2015
Phase: N/A
Study type: Interventional

The study evaluates postoperative pain, morbidity, recurrence and quality of life, comparing two different strategies in the treatment of grade III and IV hemorrhoids: transanal hemorrhoidal dearterialization with mucopexy (THD) versus hemorrhoidectomy by Ligasure™.

NCT ID: NCT02579330 Not yet recruiting - Hemorrhoids Clinical Trials

Trial on Use of Coloshield in Transanal and Anal Surgery

Start date: December 2015
Phase: N/A
Study type: Interventional

In various transanal and anal procedures it is desirable to clean the operating field from stool contamination. Thus mechanical bowel preparation is not well tolerated by patients. Enema does not provide sufficient effect. By the use of Coloshield a rectal washout might be performed and enable a clean operating field. In this randomized controlled trial the macroscopic contamination of the rectum with and without Coloshield is compared using the Boston Bowel Preparation Score (0-3).

NCT ID: NCT02402543 Completed - Hemorrhoids Clinical Trials

Pre-Emptive Analgesia in Ano-Rectal Surgery

PEAARS
Start date: June 2014
Phase: N/A
Study type: Interventional

The perianal region is the region around the anus. Administering a pain medication before a surgery starts is called preemptive analgesia. In some studies, this technique has been shown to be an effective way to reduce the pain that a patient experiences in the post-operative timeframe to a greater extent than would be expected simply from the pain medications alone. One theory of why this occurs suggests that the preemptive analgesia desensitizes brain and nerves to pain, thereby decreasing the response to painful stimuli, like surgery when they occur. This leads to a decrease in the amount of narcotic pain medication required after the procedure, which leads to less side effects and a quicker return to normal functioning. As perianal surgeries do not usually include a long stay in the hospital, controlling post-procedure pain is a priority. The use of preemptive analgesia is in other types of surgeries, such as orthopedics, is well established, but as the perianal region has not been well studied, its use is not the standard of care. This type of analgesia uses a combination of medications that are already in use for post-operative and non-operative pain control and administers them orally prior to the patient undergoing general anesthesia. The side effects of the medications are the same as if they had been given after surgery or for non-surgical pain. The concept of preemptive analgesia is established in other types of surgeries and it has solid basic science to support its use. The purpose of this randomized, double-blind, placebo controlled study is to determine if patients undergoing perianal surgeries could benefit from preemptive pain control. The primary outcome will be whether patients experience less post-operative pain. Patient post-operative consumption and latency until use of narcotic pain medication will be the secondary outcomes. The investigators believe that the patients receiving pain medications before their operation will require less pain medication after surgery, with minimal increased risk to the patient.